Page last updated: 2024-08-17

medroxyprogesterone acetate and Gonadal Dysgenesis, 46, XX

medroxyprogesterone acetate has been researched along with Gonadal Dysgenesis, 46, XX in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Calis, KA; Corrigan, EC; Kalantaridou, SN; Nelson, LM; Troendle, JF; Vanderhoof, VH1

Trials

1 trial(s) available for medroxyprogesterone acetate and Gonadal Dysgenesis, 46, XX

ArticleYear
Sexual function in young women with spontaneous 46,XX primary ovarian insufficiency.
    Fertility and sterility, 2008, Volume: 90, Issue:5

    Topics: Administration, Cutaneous; Administration, Oral; Adult; Cross-Sectional Studies; Double-Blind Method; Estrogen Replacement Therapy; Estrogens; Female; Gonadal Dysgenesis, 46,XX; Humans; Medroxyprogesterone Acetate; Primary Ovarian Insufficiency; Prospective Studies; Sexual Behavior; Sexual Dysfunction, Physiological; Surveys and Questionnaires; Testosterone; Treatment Outcome; Young Adult

2008